EVOLVE Short DAPT Study
NCT02605447
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2009
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
3 months of dual antiplatelet therapy (DAPT)
DEVICE:
SYNERGY Stent System
Sponsor
Boston Scientific Corporation